Scale -


  • Ebitda is 763 Rs Cr; Annual Growth is 68 %; Continuous Growth over 3 years; 5 Year CAGR is 24 %; in Bottom Quartile
  • PBT is 116 Rs Cr; Annual Growth is 1588 %; in Bottom Quartile
  • PAT is 199 Rs Cr; Annual Growth is 449 %; Continuous Growth over 3 years; in Bottom Quartile
  • Revenue is 3373 Rs Cr; Continuous Growth over 3 years
  • Quarterly Profit is 107 Rs Cr; in Bottom Quartile

Profitability -


  • PBDIT Margin is 22.62 %; Annual Growth is 50 %; Continuous Growth over 3 years; 5 Year CAGR is 23 %
  • PAT Margin is 5.89 %; Annual Growth is 412 %; Continuous Growth over 3 years; in Bottom Quartile

Return -


  • ROCE is 7.66 %; Annual Growth is 96 %; Continuous Growth over 3 years; 5 Year CAGR is 53 %; in Bottom Quartile
  • ROA is 2.47 %; Annual Growth is 533 %; Continuous Growth over 3 years; in Bottom Quartile
  • ROE is 4.31 %; Annual Growth is 503 %; Continuous Growth over 3 years; in Bottom Quartile
  • Asset Turnover is 40 %; Continuous Growth over 3 years; 5 Year CAGR is 19 %; in Bottom Quartile

Efficiency -


  • Current Ratio is 1.66; Annual Growth is 32 %; Continuous Growth over 3 years
  • Operating cash flow is 390 Rs Cr; Annual Growth is 1873 %; in Bottom Quartile
  • Quick Ratio is 1.12; Continuous Growth over 3 years
  • Inventory Turnover Ratio is 4.18; 5 Year CAGR is 72 %

Solvancy -


  • Contingent Liabilities is 639 Rs Cr; Continuous Decline over 3 years
  • Long term Debt is 1518 Rs Cr; Continuous Growth over 3 years; in Top Quartile; 5 Year CAGR is 44 %
  • Debt/Equity is 0.43; in Top Quartile

Quality -


  • Operating cashflow/ebitda is 51 %; Annual Growth is 1157 %; 5 Year CAGR is -21 %
  • Operating cashflow/PAT is 196 %; Annual Growth is 408 %; Continuous Growth over 3 years; in Top Quartile
  • Change in Inventories/Total Expenses is -4 %; Annual Decline is -136 %; Continuous Decline over 3 years; in Bottom Quartile
  • Exceptional Items/PBT is -36 %; Continuous Decline over 3 years; in Bottom Quartile
  • Current Tax/PAT is 9 %; in Bottom Quartile; Annual Growth is 174 %
  • Other Expenses/Total Expenses is 27 %; Continuous Growth over 3 years

Quarterly Results- overall

Annual Results- Scale

Annual Results- Liquidity

Annual Results- Profitability/Return

Annual Results- Valuation

External Ecosystem


Sector
Major Subsidiaries/Associates
Key Clients

Products


Products
Product details

Operations


Capacity/ Production
Key Facilities
Key Certifications
Raw materials
Recent News
Pharma sector stocks today, October 29: Wockhardt gains 1.75%, IPCA Lab up 1.78%, Biocon rises 1.32%
Wockhardt Reports Rs 207 Crore Loss In Q2 After Restructuring Its US Business